The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illnessOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined the relationship between the gut microbiota and psychiatric symptom severity among inpatients with serious mental illness. Researchers used 16S rRNA gene sequencing and whole genome shotgun sequencing to characterize fecal samples collected early in hospitalization. They then tested whether microbial richness and alpha diversity were associated with depression, anxiety, trauma, and suicide severity measures, and whether these microbial features predicted treatment outcome at discharge.
Who was studied?
The study population consisted of 111 adult inpatients with serious mental illness. Diagnoses, suicide severity, trauma, depression, and anxiety were assessed shortly after admission. Participants self-collected fecal swabs early in the course of their hospital stay for microbiota analysis.
What were the most important findings?
Depression and anxiety severity shortly after admission were negatively associated with bacterial richness and alpha diversity, meaning more severe symptoms corresponded to a less rich and less diverse gut microbiota. Specific bacterial taxa were identified as associated with depression and anxiety severity. Gut microbiota richness and alpha diversity measured early in hospitalization also significantly predicted depression remission by the time of discharge.
What are the greatest implications of this study?
The findings support a link between gut microbial diversity and psychiatric symptom severity in a clinical inpatient population, extending prior evidence from animal models and small human studies. Because early microbiota measures predicted depression remission at discharge, gut microbiota composition may hold value as a marker of treatment response in serious mental illness. This strengthens the rationale for further investigating the brain-gut relationship as a factor in psychiatric care and outcomes.